Report : North America Medical Isolation Gowns Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Disposable and Reusable), Product Type (Surgical and Non-Surgical), and End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others)
Disposable Segment to Dominate North America Medical Isolation Gowns Market during 2021–2028
According to a new market research study on “North America Medical Isolation Gowns Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Product Type, and End User” is expected to reach US$ 1,385.93 million by 2028 from US$ 518.34 million in 2021. The market is estimated to grow at a CAGR of 15.1% from 2021 to 2028. The report provides trends prevailing in the North America medical isolation gowns market along with the drivers and restraints pertaining to the market growth. Rising awareness regarding hospital-acquired infections is the major factor driving the growth of the North America medical isolation gowns market. However, issues associated with the stringent regulatory norms hinder the growth of North America medical isolation gowns market.
The North America medical isolation gowns market has been segmented based on type, product type, end user, and country. On the basis of type, the North America medical isolation gowns market is segmented into disposable and reusable. The disposable segment dominated the market in 2020 and reusable segment is expected to be the fastest growing during the forecast period. Based on product type, the market is segmented into surgical and non-surgical. The surgical segment dominated the market in 2020 and non-surgical segment is expected to be the fastest growing during the forecast period. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment dominated the market in 2020 and ambulatory surgical centers is expected to be the fastest growing during the forecast period. Based on country, the medical isolation gowns market is classified into US, Canada, and Mexico.
The COVID-19 pandemic outbreak was first observed in December 2019 in Wuhan (China), and it has spread to ~100 countries across the world, with the World Health Organization (WHO) stating it as a public health emergency. In the North American region, the US was profoundly affected by the outbreak of the COVID-19 pandemic. The country has marked the highest number of positive patients. Across the nation, various healthcare research centers were working only for research on COVID 19 therapeutics. Additionally, during the initial phase of the COVID-19 crisis, due to lockdown and supply chain disruptions, the demand for Medical Isolation Gowns was disrupted owing to a change in customer behaviors. As the problem moved forward, healthcare professionals realized that developing novel therapies using innovative technologies is essential to mitigate this unprecedented crisis. In the middle of this situation, governments around the world were not prepared for such a pandemic. There is no definitive treatment against COVID 19 has been established. Medical isolation gowns are among the highly consumed hospital consumables. The hospitals utilize a larger quantity of medical isolation gowns during the COVID19 pandemic and for general patients. There has been an immense rise in the demand for medical isolation gowns in the regions. To overcome this shortage, regulatory agencies such as USFDA have given revised guidelines regarding surgical gowns. The agency has also liberalized the product approval procedures to facilitate early product availability in the market. Various market players of non-healthcare businesses are taking involvement in the medical isolation gowns' productions to fulfill the high demand. The existing players are ramping up the production and supply chain for the medical isolation gowns in the region. For instance, Ferrara Manufacturing, located in New York City's historic Fashion District, has been producing Olympic uniforms for Team USA, runway garments, and formal suiting for several major luxury brands since 1987. In March 2020, however, Ferrara Manufacturing shifted its garment production from high-end fashion to medical isolation gowns for the frontline worker. Also, Accel Unite had recently developed a new design for reusable isolation gowns. Dow collaborated with nine key partners across various industries to develop and donate 100,000 isolation gowns to help frontline workers in Texas, Louisiana, and Mexico. Thus, new players' innovative product development is expected to create healthy market competition in the North American medical isolation gowns market.
Advin Health Care; Alsco, Inc.; Cardinal Health, Inc.; Medline Industries, Inc.; Mölnlycke Health Care AB; Narang Medical Limited.; SARA HEALTH CARE; and STANDARD TEXTILE CO., INC are among the leading companies in the North America medical isolation gowns market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Cardinal Health has agreed to sell its Cordis business to Hellman & Friedman for around $1 billion, with the buyer bearing on certain liabilities and the seller keeping certain working capital accounts. The transaction is expected to close in the first half of Cardinal Health's fiscal year 2022, subject to customary closing conditions and regulatory approvals.
Contact Person: Sameer Joshi
Email Id: email@example.com